INS and Insulin resistance: Antiresistin oligo treatment significantly decreased fasting serum glucose (Table 2, Res-oligo versus C-oligo group, P < 0.05) associated with improved insulin resistance, evidenced by a reduction of fasting serum insulin levels (P < 0.01) and reduced HOMA-IR values (Table 2, P < 0.05).